We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Neoleukin Therapeutics, Inc's financial performance into perspective.
February 6, 2020
December 20, 2019
Neoleukin Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 17, 2019
February 13, 2020 at 10:00 AM EST
December 5, 2019 at 2:50 PM EST